Despite its size and overall attractiveness, Brazil faces many challenges on its long journey to financial stardom.
Tobias Carlisle chats with the man behind the pseudonymous Twitter account, Bluegrass Capital.
The partnership between the research team at the University of Minnesota and Fate Therapeutics is looking at a new course of cancer treatment, which focuses on the use of natural killer (NK) cells.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
| Website: | www.fatetherapeutics.com |
| Email: | info@fatetherapeutics.com |
| Main Phone: | +1 858 875-1800 |
| Address: | 3535 General Atomics Court |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92121 |
| Exchange: | NSD |
| CEO: | J. Scott Wolchko |
| Employees: | 279 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Despite its size and overall attractiveness, Brazil faces many challenges on its long journey to financial stardom.
Tobias Carlisle chats with the man behind the pseudonymous Twitter account, Bluegrass Capital.
The partnership between the research team at the University of Minnesota and Fate Therapeutics is looking at a new course of cancer treatment, which focuses on the use of natural killer (NK) cells.
Canada is home to some of the world’s best dividend-paying stocks. Here's why.
Fate Therapeutics ($FATE) is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including
Crude oil from Canada’s tar sands is known to be one of the dirtier and more costly to process crude varieties, a fact that has been a major stumbling block in the construction of
The proposed XL leg of the Keystone Pipeline, the controversial oil-supply conduit that would funnel Canadian tar sands oil through the Upper Midwest to shipping centers in Oklahoma, is facing
President Obama has been wavering on the proposed Keystone XL extension that would complete the Keystone Oil Pipeline. In a Tuesday speech, the President said “our national interest will
I told readers yesterday to be on the alert for a “stall” as stocks ran into headwinds after a sharp rally that started Monday. a rally failure. We got a stall, but it was not the kind of
The trading style of “swing trading”, in which equities are held from 2 days for as long as several weeks, has been popular with active traders for many years. In volatile markets, entering
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 2 | 8 |
| Number of Buys | 2 | 2 |
| Number of Sells | 0 | 6 |
| Net Activity | 21054 | -17430 |
| Last 10 Buys | Shares |
|---|---|
| Chris Storgard | 1,000 |
| William H. Rastetter | 1,000 |
| Timothy P. Coughlin | 1,000 |
| John D. Mendlein | 1,000 |
| William H. Rastetter | 1,000 |
| Robert T. Nelsen | 1,000 |
| Amir Nashat | 1,000 |
| Amir Nashat | 1,000 |
| Amir Nashat | 1,000 |
| Amir Nashat | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| J. Scott Wolchko | 1,000 |
| Cindy Tahl | 1,000 |
| Daniel D. Shoemaker | 1,000 |
| J. Scott Wolchko | 1,000 |
| Daniel D. Shoemaker | 1,000 |
| Cindy Tahl | 1,000 |
| Peter Flynn | 1,000 |
| Peter Flynn | 1,000 |
| Peter Flynn | 1,000 |
| Peter Flynn | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 20 | 20 | 20 | 20 |
| Low Target Price Estimate | 12 | 12 | 12 | 12 |
| Mean Target Price Estimate | 17.8 | 17.8 | 17.8 | 17.8 |
| Standard Deviation | 3.35 | 3.35 | 3.35 | 3.35 |
| Date of Most Recent Estimate | 05/10/18 | 05/10/18 | 05/10/18 | 05/10/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-01 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2018-05-14 |
| UPLOAD | Correspondence from the SEC to the Filer | 1 | 2018-05-11 |
| CORRESP | Correspondence from the Filer to the SEC | 2 | 2018-05-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 58 | 2018-05-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2018-05-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-04 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.67 | 1.67 | 1.67 | 1.67 |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
